Company Overview
Development and licensing of its own healthcare software products (Miya,Patientrack, Smartpage and ExtraMed), the reselling of selected healthcare software products from its strategic partners and the delivery of product implementation, product support and maintenance, systems integration and data analysis services to healthcare customers in Australia, New Zealand and the UK.
Website | www.alcidion.com |
---|---|
Head Office | South Yarra VIC |
Registry | Computershare Investor Services |
CEO | Katrina (Kate) Doyle (Quirke) |
Chair Person | Rebecca Wilson |
GICS Industry | Health Care Equipment & Services |
Sub Industry | Health Care Technology |
Sector | Health Care |
Market Cap | $165 m |
---|---|
Shares on Issue | 1,268 b |
Status | Trading |
Last Price | |
Change | |
52 Week H/L | |
VWAP | |
Bid/Ask |
Directors and Management
Ms Rebecca Wilson
Non-Executive Director,Non-Executive Chairman 31/07/2017
Ms Wilson has more than 20 years experience working within the healthcare, technology and life science sectors providing advice on stakeholder communications, issues management, investor and corporate relations, and business strategy to private and public companies, corporations, governments, and asset managers. She advises boards and executive teams on investor relations and commercial strategies and has experience in transactions, including more than 60 IPOs, M&A transactions, and hundreds of capital raisings. Rebecca is an Executive Director of consulting firm WE Worldwide. She is a member and graduate of the Australian Institute of Company Directors (AICD).
BA (Journalism), PGAppFin&Inv, FINSIA,GMAICD Female
Mr Simon Chamberlain
Non-Executive Director 01/07/2019
Mr has more than 20 years' experience in executive roles at companies including Experian, Medibank Private, Qantas and MedAdvisor and in his current role, leading strategy and marketing at the high growth residential services business, Detector Inspector. Simon led Qantas' entrance into the online hotels business, establishing a profitable, high growth new division. At Medibank, Simon had responsibility across customer channels, data and customer experience. Gaining a better understanding of the complex challenges facing the wider health system led to Simon's role leading strategy for MedAdvisor, where he supported the global expansion of its health technology business.
BCom(Acc),LLB(Hons) Male
Mr Nicholas (Nick) Paul Dignam
Non-Executive Director 22/02/2016
Mr Dignam is a Partner of Fortitude Investment Partners, a growth capital focused private equity firm. He is responsible for originating new investment opportunities, working with portfolio companies to deliver growth and managing exit processes. Nick has more than ten year's experience working in private equity. Nick also serves as a director on the Board of a number of Fortitude's portfolio companies including Better Medical, Birch & Waite, Sunfresh Salads, Wild Breads and GM Hotels. Nick has previously served on the Boards of HPS (outsourced hospital pharmacy services) and Readify (software development services). Prior to establishing Fortitude, Nick was the Head of Growth Capital in Blue Sky's Private Equity division, and prior to this he was an investment director with midmarket private equity firm Catalyst Investment Managers. Before Catalyst Nick spent three years with Ernst & Young in the corporate finance division.
BCom, LLB, MAppFin Male
Professor Malcolm Pradhan
Executive Director 22/02/2016
Professor Pradhan has over 25 years of experience in Medical Informatics. Malcolm has been a advocate for interoperability, and a sustainable health care system using smart data-driven IT systems that improve patient safety, reduce clinician workloads and support new models of care.
MBBS, PhD, FACHI Male
Ms Victoria Weekes
Non-Executive Director 01/09/2021
Ms Weekes has experience in the banking and finance sectors. Ms Weekes was the immediate past Acting Chair of the Sydney Local Health District Board and is an experienced Non-Executive Director with current appointments including FINSIA, NSW Treasury Audit and Risk, and St George Community Housing. Ms Weekes will Chair Alcidion's Risk Committee from 01/09/2021.
BCom, LLB, FAICD,FFinSIA, Chartered Banker Female
Ms Katrina (Kate) Elizabeth Doyle (Quirke)
Chief Executive Officer,Executive Director,Managing Director 03/07/2018
Ms Quirke has more than 25 years of experience in the healthcare information technology sector. She has been involved in large systems procurements and implementations of healthcare information technology across Australia, New Zealand and South East Asia. Kate's background involves holding leading management roles at some of the largest healthcare software firms where she has had an impact on strategic product direction across the health sector and believes astute application of information technology will support the transformation of healthcare delivery worldwide.
Female
Mr Daniel Sharp
Non-Executive Director 01/09/2021
Mr Sharp has more than 30 years' experience in capital markets globally, advising the boards of technology and healthcare-based organizations, and with a network of institutional and private wealth investors globally. He is an immediate past Executive Director of Canaccord Genuity and previously held executive senior corporate banking roles with Shaw and Partners and Lodge Partners.
BEco,LLB,CFA(Charter Holder) Investment Banker Male
Top 20 Shareholders
Name | Shares | % | |
---|---|---|---|
1. | Mr Malcolm Pradhan | 134,582,403 | 12.84 |
2. | Mr Raymond Blight | 95,828,781 | 9.14 |
3. | J P Morgan Nominees Australia Pty Limited | 55,835,785 | 5.33 |
4. | Isle of Wight Pty Limited | 49,405,192 | 4.71 |
5. | Caledonia Nominees Pty Limited | 35,976,377 | 3.43 |
6. | Mrs Katrina Doyle | 27,793,199 | 2.65 |
7. | Rewmicman Pty Limited | 26,026,606 | 2.48 |
8. | Rangiora-London Pty Limited | 25,102,251 | 2.40 |
9. | Sandhurst Trustees Limited <JMFG CONSOL A/C> | 24,453,360 | 2.33 |
10. | MNMD Pty Limited | 18,668,086 | 1.78 |
11. | Citicorp Nominees Pty Limited | 18,102,425 | 1.73 |
12. | HSBC Custody Nominees (Australia) Limited | 16,552,966 | 1.58 |
13. | Mr Colin MacKinnon + Mrs Maree MacKinnon | 9,676,550 | 0.92 |
14. | National Nominees Limited | 9,618,072 | 0.92 |
15. | Sandhurst Trustees Limited <CYAN C3G FUND A/C> | 7,819,114 | 0.75 |
16. | Rewmicman Pty Limited (i) | 7,533,835 | 0.72 |
17. | BNP Paribas Noms Pty Ltd | 6,233,372 | 0.59 |
18. | Emerald Shares Pty Limited | 6,118,750 | 0.58 |
19. | Cs Third Nominees Pty Limited | 5,680,121 | 0.54 |
20. | Mr Vivek Ramakrishnan + Miss Nisha Srinivasan | 5,593,121 | 0.53 |
Director Transactions
Date | Name | Qty | Value | Direction | Notes |
---|---|---|---|---|---|
17/05/2021 | Simon Chamberlain | 295,000 | $100,300 | Buy | On-market trade. |
17/05/2021 | Katrina (Kate) Doyle (Quirke) | 11,481,273 | $3,903,632 | Sell | On-market trade. As per announcement on 18/05/2021. |
11/05/2021 | Rebecca Wilson | 22,597 | $7,231 | Issued | Participation in share purchase plan. |
11/05/2021 | Rebecca Wilson | 15,327 | $4,904 | Issued | Participation in share purchase plan. |
11/05/2021 | Raymond Blight | 93,750 | $30,000 | Issued | Participation in share purchase plan. |
20/11/2020 | Malcolm Pradhan | 563,309 | $107,028 | Issued | Issue of securities. 563,309 - Performance Rights |
20/11/2020 | Katrina (Kate) Doyle (Quirke) | 2,547,511 | $484,027 | Issued | Issue of securities. 2,547,511 - Performance Rights |